MacroGenics (MGNX) VP Beth Smith logs RSU vesting and tax share withholding

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

MacroGenics VP, Controller & Treasurer Beth Ann Smith reported routine equity compensation activity involving restricted stock units (RSUs) and common stock. On February 7, 2026, 2,617 RSUs converted into 2,617 shares of common stock at an exercise price of $0, with 1,011 shares of common stock withheld at $1.81 per share, leaving 11,138 shares directly owned afterward. On February 8, 2026, a further 1,583 RSUs converted into 1,583 shares of common stock at $0, with 612 shares withheld at $1.81 per share, resulting in 12,109 common shares directly owned. RSUs convert into company stock on a one-for-one basis, and remaining RSU balances after these transactions were 5,233 and 1,584 units for the two respective grants.

Insider Trade Summary

4,200 shares exercised/converted

Mixed 6 txns

Insider Smith Beth Ann

Role VP, Controller & Treasurer

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Unit	1,583	$0.00	--
Exercise	Common Stock	1,583	$0.00	--
Tax Withholding	Common Stock	612	$1.81	$1K
Exercise	Restricted Stock Unit	2,617	$0.00	--
Exercise	Common Stock	2,617	$0.00	--
Tax Withholding	Common Stock	1,011	$1.81	$2K

Holdings After Transaction: Restricted Stock Unit — 1,584 shares (Direct); Common Stock — 12,721 shares (Direct)

Footnotes (1)

Restricted stock units convert into the Company's stock on a one-for-one basis. On February 7, 2025, the reporting person was granted 7,850 restricted stock units, vesting in three equal installments beginning on the first anniversary of the grant date. On February 8, 2024, the reporting person was granted 4,750 restricted stock units, vesting in three equal installments beginning on the first anniversary of the grant date.

Form 4 Insider Transactions: What Each Field Means →

02/10/2026 - 06:16 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Smith Beth Ann

(Last)

(First)

(Middle)

9704 MEDICAL CENTER DRIVE

(Street)

ROCKVILLE

20850

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
MACROGENICS INC [ MGNX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	VP, Controller & Treasurer

3. Date of Earliest Transaction (Month/Day/Year)
02/07/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	02/07/2026		M		2,617	A	⁽¹⁾	12,149	D
Common Stock	02/07/2026		F		1,011	D	$1.81	11,138	D
Common Stock	02/08/2026		M		1,583	A	⁽¹⁾	12,721	D
Common Stock	02/08/2026		F		612	D	$1.81	12,109	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Unit	⁽¹⁾	02/07/2026		M			2,617	⁽²⁾	⁽²⁾	Common Stock	2,617	$0	5,233	D
Restricted Stock Unit	⁽¹⁾	02/08/2026		M			1,583	⁽³⁾	⁽³⁾	Common Stock	1,583	$0	1,584	D

Explanation of Responses:

1. Restricted stock units convert into the Company's stock on a one-for-one basis.

2. On February 7, 2025, the reporting person was granted 7,850 restricted stock units, vesting in three equal installments beginning on the first anniversary of the grant date.

3. On February 8, 2024, the reporting person was granted 4,750 restricted stock units, vesting in three equal installments beginning on the first anniversary of the grant date.

Remarks:

	/s/ Beth Smith	02/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider transactions did MacroGenics (MGNX) report for Beth Ann Smith?

Beth Ann Smith reported RSU vesting and related common stock transactions. On February 7 and 8, 2026, RSUs converted into common shares at $0 exercise price, with portions of the resulting stock withheld at $1.81 per share, typically for tax obligations.

How many MacroGenics common shares does Beth Ann Smith hold after these Form 4 transactions?

After the reported transactions, Beth Ann Smith directly owns 12,109 MacroGenics common shares. This figure reflects RSU conversions into stock on February 7 and 8, 2026, and share withholdings at $1.81 per share associated with those vesting events.

What restricted stock unit activity for MGNX did the Form 4 disclose?

The Form 4 shows RSUs converting one-for-one into MacroGenics stock. On February 7, 2026, 2,617 RSUs converted, and on February 8, 1,583 RSUs converted. Remaining reported RSU balances were 5,233 units from a 2025 grant and 1,584 units from a 2024 grant.

At what price were MacroGenics shares withheld in Beth Ann Smith’s transactions?

Common shares were withheld at $1.81 per share. On February 7, 2026, 1,011 shares were withheld at this price, and on February 8, 612 shares were withheld at the same price, consistent with share withholding commonly used to cover tax obligations on RSU vesting.

What are the key details of Beth Ann Smith’s RSU grants mentioned in the Form 4?

One grant on February 7, 2025 covered 7,850 RSUs vesting in three equal annual installments from the first anniversary. Another grant on February 8, 2024 covered 4,750 RSUs, also vesting in three equal annual installments beginning on the first anniversary of the grant date.

What role does Beth Ann Smith hold at MacroGenics (MGNX) according to the filing?

Beth Ann Smith is identified as an officer of MacroGenics, serving as VP, Controller & Treasurer. The reported RSU vesting and common stock transactions reflect her compensation-related equity awards as an executive within the company’s leadership team.